PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help fight TB in HIV patients?
Disease control CompletedThis study looked at whether adding metformin, a diabetes drug, to standard tuberculosis (TB) treatment is safe and tolerable for people also living with HIV. 112 adults with TB and HIV took either standard TB medicines alone or with metformin for 11 weeks. Researchers monitored …
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New TB drug combo shows promise in early trial
Disease control CompletedThis phase IIb trial tested an experimental antibiotic called delpazolid, added to a standard three-drug regimen (bedaquiline, delamanid, moxifloxacin), in 76 adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. The main goals were to check safety and how the drug …
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC
-
TB patients given zinc and selenium show improved immune response
Disease control CompletedThis completed trial tested whether zinc and selenium supplements could boost the immune system of tuberculosis patients. Researchers gave 90 adults with pulmonary TB either fortified cookies or a supplement called Myrin P Fort, and measured changes in body measurements, blood co…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 26, 2026 17:30 UTC
-
New drug cocktail shows promise against Drug-Resistant TB
Disease control CompletedThis study tested a combination of three drugs—bedaquiline, pretomanid, and linezolid—in 109 people with extensively drug-resistant TB (XDR-TB) or multi-drug resistant TB (MDR-TB) that didn't respond to other treatments. Participants took the drugs for 6 to 9 months. The goal was…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC
-
Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
Diagnosis CompletedThis study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to …
Matched conditions: PULMONARY TUBERCULOSIS
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Can a chest X-Ray and blood test quickly rule out TB?
Diagnosis CompletedThis study tested two new tools for diagnosing tuberculosis (TB): a software that analyzes chest X-rays (CAD4TB) and a blood test that measures C-reactive protein (CRP). Researchers enrolled 1,400 adults with TB symptoms in Lesotho and South Africa. They compared these tests to s…
Matched conditions: PULMONARY TUBERCULOSIS
Sponsor: Klaus Reither • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
VR training matches Real-Life mock homes for nursing skills
Knowledge-focused CompletedThis study tested whether a virtual reality (VR) room called VR CAVE can teach community health nursing skills as effectively as a physical mock home. 150 final-year nursing students practiced home visits for patients with COPD and tuberculosis in both settings. Results showed bo…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: NA • Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC